| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-55 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-89 |
| filingDate |
1993-09-23^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3897de52d879ceadff80e54df100fcc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b0199c928abce3fac76a92ef351d51e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_290dad1941458e8afd8cd03e48030a8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d158ba04f1841c12eb769dc8028e8e5f |
| publicationDate |
1994-04-06^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0590520-A1 |
| titleOfInvention |
Acylsulphonamido and sulphonamidopyridine-2-carboxylic acid esters, pyridine-n-oxides thereof, a process for their preparation and their use as medicaments |
| abstract |
The invention relates to acylsulfonamido and sulfonamido pyridine-2-carboxylic acid esters and their pyridine N-oxides of the general formula I. wherein A = R³ and B = X-NR⁵R⁶ or B = R³ and A = X-NR⁵R⁶ and are.n n n The compounds are suitable as medicaments for fibrotic diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6251827-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100413848-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0765871-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5726305-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9067922-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6093730-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9916744-A1 |
| priorityDate |
1992-10-02^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |